
BACKGROUND: Gastroesophageal reflux disease (GERD) is a common comorbidity of chronic obstructive pulmonary disease (COPD) and asthma. However, limited information is available on GERD among community-sourced patients with COPD and asthma in China. This study aimed to assess the prevalence of GERD and its association with respiratory symptoms and airway reversibility in these patients from the general population. METHODS: The China Pulmonary Health (CPH) study, a national cross-sectional survey, enrolled 57,779 adults aged ≥20 years from June 2012 to May 2015. Participants completed standard questionnaires and underwent pulmonary function tests. GERD was defined using the Gastroesophageal Reflux Disease Questionnaire (GerdQ). Airway reversibility was assessed via post-bronchodilator pulmonary function changes. Multivariate regressions examined the association of GERD with respiratory symptoms and airway reversibility. RESULTS: In total, 47,226 participants were included in the final analysis. The prevalence of GERD was 6.62% (95% confidence interval [CI]: 5.89-7.34%) in patients with COPD, and 13.73% (95% CI: 12.19-15.27%) and 12.38% (95% CI: 9.84-14.93%) in patients with asthma and asthma with airflow limitation, respectively. GERD was associated with nasal symptoms, cough, sputum, wheezing, and dyspnea in patients with COPD. GERD was also associated with nasal symptoms and dyspnea in patients with asthma. After adjusting for confounders, the asthma group with GERD had smaller postbronchodilator changes in forced expiratory volume in 1 s (FEV1) compared with those without GERD (B = -0.030, 95% CI: -0.055 to -0.005, P = 0.018), and the association remained after further adjusting for respiratory symptoms (B = -0.033, 95% CI: -0.058 to -0.008, P = 0.009). But postbronchodilator changes in FEV1 or forced vital capacity (FVC) did not differ between COPD patients with and without GERD. CONCLUSIONS: GERD is prevalent and significantly associated with respiratory symptoms in patients with COPD and asthma. In patients with asthma, those with GERD had worse airway reversibility.
ABSTRACT: Pregnancy represents a critical stage in which both maternal and fetal health are of paramount importance. This review systematically examines the temporal dynamics of maternal microbial communities across multiple anatomical niches-including the vaginal, intestinal, and oral ecosystems-during pregnancy, and explores their profound connections with gestational health. We highlight the specific associations between site-specific microbial dysbiosis and adverse outcomes such as preterm birth, gestational diabetes, and preeclampsia. In addition, we delineate the mechanisms by which the immune microenvironment at the maternal-fetal interface maintains dynamic equilibrium under microbial regulation, and underscores the role of microbial metabolites as transgenerational signaling molecules critical for fetal development. Furthermore, we dissect the pathological disruption of the "microbiota-immune-metabolism" network in pregnancy-related disorders and evaluate the potential of targeted strategies-including probiotic supplementation and nutritional interventions-to restore microbial homeostasis and improve maternal and neonatal outcomes. Finally, we emphasize the contribution of breast milk microbiota and immune components to offspring immune programming and outline future translational research directions, aiming to provide a scientific foundation for microbiota-based monitoring and early intervention in pregnancy health.
Abstract The incidence of cardiovascular diseases (CVD) together with their associated risk factors increasingly impact population health. According to the data provided in the 2025 Annual Report on Cardiovascular Diseases in China, the crude incidence of cardiovascular and cerebrovascular diseases among Chinese residents aged ≥18 years, including acute myocardial infarction (AMI), angina pectoris treated by percutaneous transluminal coronary angioplasty/stent implantation and/or coronary artery bypass grafting, stroke, and sudden cardiac death was 639.46 per 100,000 (age-standardized incidence rate: 651.47 per 100,000). Crude AMI incidence was 91.47 per 100,000. Crude stoke incidence was 499.78 per 100,000. In addition to interpreting the key findings of CVD incidence and mortality in China, we provide updated data on associated risk factors, including tobacco use, diet and nutrition, physical activity, overweight and obesity, hypertension, dyslipidemia, diabetes, chronic kidney disease, sleep and mental health, and environmental factors. Statistics on diagnosis and treatment of CVD diseases, updates on CVD research and health economic studies of CVD provide a scientific foundation for advancing CVD prevention and control, as well as for informing relevant public health policy development.
Abstract Stroke is the leading cause of death and disability among the Chinese population and a leading cause of hospitalization in China, posing a serious threat to public health and socioeconomic development. Based on the China Stroke Prevention and Treatment Report 2024, this article summarizes the epidemiological characteristics of stroke in China and highlights its growing economic burden. Given China’s risk factor profile, sustained efforts to improve hypertension awareness, treatment, and control, particularly by strengthening hypertension screening in young adults, may represent one of the most cost-effective strategies for stroke prevention and management in the country. Although reperfusion therapy and related clinical research in China have largely aligned with international standards, approximately half of patients still experience unfavorable outcomes after reperfusion therapy. Improving outcomes in these patients should therefore be a major focus of future research. Under the strategic guidance of government authorities and with the expertise of stroke specialists, continued efforts to advance stroke prevention and management practices and strengthen a comprehensive prevention and treatment system tailored to China’s national context should remain a key priority.